New hope pill tested for tough blood cancers
Disease control
Recruiting now
This is the first study in people to test a new oral medication called GLB-001. It aims to find a safe and effective dose for adults with advanced forms of acute myeloid leukemia or myelodysplastic syndromes that have returned or not responded to other treatments. The main goals …
Phase: PHASE1 • Sponsor: GluBio Therapeutics Inc. • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC